PRECISION. STABILITY. CONFIDENCE IN EVERY TEST. HOW RANDOX QC OUTPERFORMED COMPETITORS


IN A HIGH - VOLUME EUROPEAN LAB


Objective: Independent comparative trial to assess the performance of Randox Quality Control materials versus equivalent competitor controls. Evaluating performance under real-world quality control (QC) conditions.


RANDOX QC EVALUATED


• Cardiac Controls • Chemistry Controls • Immunoassay Controls


• Immunoassay Speciality I Controls • Serology Controls • Specific Proteins Controls


THE TRIAL APPROACH


Direct comparison using lab’s existing QC protocols


Performance


monitored via Coefficient of Variation (CV)


INITIAL RESULTS CV Performance


100 120


20 40 60 80


0 Randox Randox Competitor Biorad


Randox QC demonstrated lower CVs across 110 tests, highlighting greater precision, with testing conducted over 7 days onboard compared to the competitor QC’s 1–2 days.


CV performance


10 15 20 25 30 35 40


0 5


Difference insignificant Randox Randox Competitor Biorad


A follow-up trial evaluating clinical chemistry controls for both Randox and competitor QC showed that Randox controls maintained superior long-term stability.


KEY TAKEAWAYS


Stable and precise performance


randox.com


Lower CVs across a wide analyte panel


marketing@randox.com Visit store.randox.com to buy directly from Randox today


Reliable long-term onboard stability


Difference


103 analytes including: Calcium, Albumin, TSH,


Troponin I, Vitamin D, & more


Tested up to


three QC levels per analyte


EXTENDED 7-DAY TRIAL CV Performance


CV performance


Number of tests/controls with better CV


Number of tests/controls with better CV


Number of tests/controls with better CV


Number of tests/controls with better CV


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60